In a Cyp4a12 transgenic mouse model of 20-HETE-dependent hypertension, Gpr75 knockdown significantly reduced doxycycline-induced blood pressure elevation, decreased ACE expression, and improved endothelial dysfunction [6]. The gene discussed is ACE; the disease is endothelial dysfunction.